Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

AstraZeneca picture

AstraZeneca sues FDA over generic Seroquel

March 14, 2012
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics

AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …

News

Ranbaxy launches generic Lipitor in Europe

March 6, 2012
Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics

Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date.  The Indian …

News

Pfizer closes in on $545m China generics deal

February 20, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics

Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China.  …

News

Hospira faces lawsuits from disgruntled investors

January 9, 2012
Manufacturing and Production Hospira, generics, manufacturing

Angry investors in US generic drugmaker Hospira have filed a class action lawsuit against the company, alleging that it misled …

News

Pfizer hatches mail order plan for Lipitor

November 23, 2011
Sales and Marketing Lipitor, Pfizer, US, generics

Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …

News
e

Teva sees modest growth as US sales fall

November 3, 2011
Business Services, Sales and Marketing Teva, generics

Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …

News

Dr Reddy’s says two plants clear FDA inspections

October 28, 2011
Manufacturing and Production Dr Reddy's, FDA 483s, India, generics

Two manufacturing facilities operated by Indian drugmaker Dr Reddy’s Laboratories successfully passed inspections by the FDA, although a plant in …

News

Health service’s £1bn patent expiry windfall

October 14, 2011
Sales and Marketing generics, patent expiry

Patent expiries could shave £1 billion from  the NHS drugs bill, and could yield major savings by 2015 for the …

Feature

Actavis plans ‘major’ sales expansion in Latin America

October 6, 2011
Sales and Marketing Actavis, emerging markets, generics

Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …

News

AZ’s Nexium faces generic competition in the UK

September 6, 2011
Nexium, Ranbaxy, generics

Generic specialist Ranbaxy has launched its version of AstraZeneca’s anti-ulcer blockbuster Nexium in the UK. It will be available in …

News

Spain to cut 2.4 billion euros from drugs bill with new generics rules

August 24, 2011
Sales and Marketing Spain, generic prescribing, generics

The Spanish government has passed new laws to increase generic prescribing and cut billions of euros from the country’s drugs …

News

Generic user fees could boost FDA inspection powers

August 22, 2011
Manufacturing and Production Mylan, generics, pharma manufacturing news

Generic drugmakers have forged a tentative deal with the US government that could see user fees being used to help …

News

Pfizer triumphs in US Viagra patent trial

August 17, 2011
Sales and Marketing Pfizer, generics, viagra

Pfizer has won a US patent infringement case against generics giant Teva, stopping the company from making its own version …

News

UK suing Servier over alleged generic blocking

June 7, 2011
Sales and Marketing Peridopril, Servier, generics

The UK government is taking Servier to court for allegedly blocking generic versions of its blood pressure drug Perindopril from …

News

Teva plans Japan expansion with Taiyo buy

May 17, 2011
Sales and Marketing Taiyo, Teva, generics

Teva is to acquire a majority stake in Taiyo, Japan’s third largest generics company for $460 million in cash. The …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024